IHS Chemical Week

Chemical Week Magazine :: Business & Finance :: Asia/Pacific

DSM to Participate in Biopharmaceutical Project in Australia

8:22 AM MDT | May 14, 2010 | DEEPTI RAMESH

DSM Biologics, a DSM subsidiary, says it has signed preliminary agreements to enter into a partnership with state and local authorities in Australia to build and operate a mammalian biopharmaceutical manufacturing facility at Brisbane. The facility will be the first major mammalian contract manufacturing organization in Australia, DSM says. The Queensland and Australian governments will provide full financial funding for the facility, which forms part of a 10-year strategic biotechnology plan. DSM will provide no capital but it will supply technological expertise...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa